APA (7th ed.) Citation

LL, W., JR, B., M, N., F, B., A, K., & SA, A. (2025). Advancing COPD management through novel pharmacological agents: Ensifentrine and dupilumab. Breathe (Sheffield, England), 21(4), 250206. https://doi.org/10.1183/20734735.0206-2025

Chicago Style (17th ed.) Citation

LL, Walkon, Burmeister JR, Nazmifar M, Bohler F, Kochanowska-Karamyan A, and Allen SA. "Advancing COPD Management Through Novel Pharmacological Agents: Ensifentrine and Dupilumab." Breathe (Sheffield, England) 21, no. 4 (2025): 250206. https://doi.org/10.1183/20734735.0206-2025.

MLA (9th ed.) Citation

LL, Walkon, et al. "Advancing COPD Management Through Novel Pharmacological Agents: Ensifentrine and Dupilumab." Breathe (Sheffield, England), vol. 21, no. 4, 2025, p. 250206, https://doi.org/10.1183/20734735.0206-2025.